 |
Date: Thursday, October 17
Time: 08:00-09:00
Session Hall 3 (Auditório II)
|
Type 1 diabetes in Very Young Children – Challenges and Opportunities
| 1. The plasticity of the young age and its effect on future health |
Prof. Tadej Battelino |
| 2. The therapeutic approach to address the challenges in the very young with type 1 diabetes |
Dr. Fiona Campbell |
| 3. MiniMed 780G system balancing outcomes, safety and quality of life: the LENNY study |
Assoc. Prof. Klemen Dovč |
| 4. To be confirmed |
|
 |
Date: Thursday, October 17
Time: 08:00-09:00
Session Hall 2 (Auditório VIII)
|
Let the Kids Be Kids: Optimizing Diabetes Care with Control-IQ Technology
The Tandem Diabetes Care symposium will showcase how Tandem advanced technology empowers young patients with type 1 diabetes to live more freely and enjoy a higher quality of life. The session focuses on three key aspects:
- Proven Control-IQ technology results that offer reliable blood glucose control
- Personalized treatment options that help patients thrive by tailoring care to their unique needs
- Ease of use
| Dr. Torben Biester will delve into the first two points by presenting compelling meta-analysis results that showcase the effectiveness of Control-IQ technology. He will also share insights from his own research and case studies that demonstrate how to tailor treatment by adjusting basal rates and utilizing Sleep Activity to meet the needs of young patients. |
Dr. Torben Biester |
| Dr. Laurel Messer will present updates on Dexcom G7 connectivity, as well as the upcoming launches of the Tandem t:slim mobile app and Tandem Source platform. Her discussion will demonstrate how Tandem technology is accessible and convenient for both healthcare professionals and patients. |
Dr. Laurel Messer |
 |
Date: Thursday, October 17
Time: 14:00-15:15
Session Hall 3 (Auditório II)
|
Transforming Pediatric Diabetes Management: The Power of Early CGM, Improved Access, and Dexcom’s Seamless Integration with AID Systems
|
This presentation provides an update on the current pediatric diabetes landscape, featuring insights from leading experts on innovative technologies, such as Dexcom G7, and educational strategies to improve patient outcomes.
|
Dr. Torben Biester |
|
Dr. Peter Adolfson will share his experience increasing access to real-time CGM in a pediatric clinic from 2013 to 2023, emphasizing the importance of a structured approach and demonstrating results to payers and decision-makers. He will compare type 1 diabetes management in Norway and Sweden, presenting similarities and differences between their health registries and outcomes.
He will discuss the importance of educational materials for Dexcom G4, G5, G6, and G7, especially during a pandemic. He will highlight current efforts in the UK and present health economic outcomes from a study comparing MDI, CSII, and AID with Dexcom G6. Finally, he will examine differences in access to technologies and care between pediatric and young adult clinics, showcasing strategies to improve outcomes in young adults.
|
Dr. Peter Adolfsson |
 |
Date: Thursday, October 17
Time: 14:00-15:15
Workshop Room (Auditório III + IV)
|
The Omnipod 5 Era: Celebrating More of Life with a Simple and Effective AID Solution
| Improved Glycaemic Results that Matter: An Endocrinologist’s Perspective |
Dr. Dorothee Deiss |
| The Power of Simplicity for Education and Onboarding: A Diabetes Educator’s Perspective |
Mr. John Pemberton |
| Celebrating More of Life: A Personal Perspective |
Guest Podder |
